RWB
PPH icon

RMR Wealth Builders’s VanEck Pharmaceutical ETF PPH Stock Holding History

RMR Wealth Builders’s Portfolio PPH Stock Details PPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-2,189
Closed -$208K – 268
2024
Q3 		$208K Buy
+2,189
New +$208K 0.02% 246

Other funds holding PPH

Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
AT
Avalon Trust Santa Fe, New Mexico $1.45B AUM 35.31% 1-Year Est. Return
JSAM
J. Safra Asset Management New York $1.86B AUM 22.95% 1-Year Est. Return
MTWSIF
Mivtachim The Workers Social Insurance Fund Tel Aviv, Israel $789M AUM 73.25% 1-Year Est. Return
MIM
Miller Investment Management West Conshohocken, Pennsylvania $1.01B AUM 13.96% 1-Year Est. Return
Thrivent Financial for Lutherans
Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return
AWC
Adamsbrown Wealth Consultants Wichita, Kansas $530M AUM 23.21% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return

RMR Wealth Builders's PPH Position: Q4 2024 in Review

RMR Wealth Builders sold out of VanEck Pharmaceutical ETF (PPH) in Q4 2024, closing a stake of 2,189 shares — an estimated $208K sold.

RMR Wealth Builders first reported a position in PPH in Q3 2024 and held it in 1 quarter. The position peaked at $208K in Q3 2024. 142 funds tracked by Wall St. Rank hold PPH as of Q4 2024.

  • RMR Wealth Builders reported no remaining VanEck Pharmaceutical ETF position as of Q4 2024 after selling out during the quarter.
  • RMR Wealth Builders sold 2,189 VanEck Pharmaceutical ETF shares in Q4 2024, an estimated $208K.
  • RMR Wealth Builders first reported a position in VanEck Pharmaceutical ETF in Q3 2024 and held it in 1 quarter.
  • RMR Wealth Builders's VanEck Pharmaceutical ETF position peaked at $208K in Q3 2024.
  • 142 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q4 2024.

Based on RMR Wealth Builders's 13F filing for Q4 2024, filed 10 Jan 2025.